Acadia Pharmaceuticals Inc

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC ACAD

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/8/2026

Shares

30,168

Value ($000)

670

Weight

0.0%

2025 Q2 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/8/2026	670	0.0%	30,168	3/31/2026
2025 Q4	1/8/2026	760	0.0%	28,221	12/31/2025
2025 Q3	10/29/2025	640	0.0%	29,727	9/30/2025
2025 Q2	7/10/2025	511	0.0%	24,375	6/30/2025